Project Details
Description
ARO-ENAC is being developed to treat people with Cystic Fibrosis by blocking the expression of a protein which may lead to improved mucus hydration and clearance and may prevent further lung injury.
Status | Finished |
---|---|
Effective start/end date | 10/1/01 → 12/1/21 |
Funding
- Social Sciences and Humanities Research Council of Canada: US$5,811,707.00
ASJC Scopus Subject Areas
- Genetics(clinical)
- Pulmonary and Respiratory Medicine
- Pharmacology
- Medicine(all)
- Organic Chemistry
- Renewable Energy, Sustainability and the Environment